MUC1 and cancer: Important leads have suggested that MUC1 is a promising target for the development of vaccines and a number of MUC1 peptide based cancer vaccines are currently in clinical trials (Kufe, 2009; Lakshminarayanan et al., 2012; Singh & Bandyopadhyay, 2007).